Program evaluation of GLA:D® Australia: Physiotherapist training outcomes and effectiveness of implementation for people with knee osteoarthritis - PubMed
- ️Fri Jan 01 2021
Program evaluation of GLA:D® Australia: Physiotherapist training outcomes and effectiveness of implementation for people with knee osteoarthritis
Christian J Barton et al. Osteoarthr Cartil Open. 2021.
Abstract
Objective: Evaluate the implementation of Good Life with osteoArthritis from Denmark (GLA:D®) for knee osteoarthritis in Australia using the RE-AIM QuEST (Reach, Effectiveness, Adoption, Implementation, Maintenance Qualitative Evaluation for Systematic Translation) framework.
Design: Physiotherapists completed surveys before and after GLA:D® training (2017-2020) to assess practices, and barriers and enablers to implementation. Patients completed online baseline, 3-month (post-treatment) and 12-month patient reported outcomes. Effective implementation was defined as within-participant moderate effect size (ES, ≥0.50) for average pain (100 mm VAS) and Knee Injury and Osteoarthritis Outcome Score quality of life scores (KOOS-QoL), and small effect size (≥0.20) for health-related quality of life (EQ-5D-5L).
Results: Reach : 1064 physiotherapists and 1945 patients from all states and territories participated. Key barriers included out-of-pocket cost to patients, and program suitability for culturally and linguistically diverse communities. Effectiveness: Following training, more physiotherapists reported discussing treatment goals and weight management, and prescribing supervised, neuromuscular exercise. Patient outcomes at 3- and 12-months (n = 1044 [54%] and 927 [48%]) reflected effective implementation, including reduced pain (ES, 95%CI = 0.72, 0.62-0.84; and 0.65, 0.54-0.77) and improved KOOS-QoL (0.79, 0.69-0.90; and 0.93, 0.81-1.04) and EQ-5D-5L (0.43, 0.31-0.54; and 0.46, 0.35-0.58) scores. Adoption: 297 sites (264 private, 33 public) implemented GLA:D®. Implementation: Most patients completed at least one education (90%), and 10 exercise-therapy (78%) sessions. Adequate staffing to support program delivery was a key enabler. Maintenance: 99% of sites (293/297) continued offering the program in July 2020.
Conclusion: Training changed practice and was associated with effective widespread implementation of GLA:D® in Australia.
Keywords: Education; Exercise; Implementation; Osteoarthritis; Physiotherapy; Program evaluation.
© 2021 The Authors.
Conflict of interest statement
CJB, JLK and KMC are program leads of GLA:D® Australia, which is a not for profit implementation initiative. Their institution has received payment for training GLA:D® practitioners. ER and STS are the co-founders of Good Life with Osteoarthritis in Denmark (GLA:D®), a not for profit initiative hosted at University of Southern Denmark aimed at implementing clinical guidelines for osteoarthritis in clinical practice. STS has received grants from The 10.13039/501100003554Lundbeck Foundation, personal fees from Munksgaard and TrustMe-ED, all of which are outside the submitted work. The authors affirm that they have no financial affiliation (including research funding) or involvement with any commercial organization that has a direct financial interest in any matter included in this manuscript, except as disclosed in an attachment and cited in the manuscript.
Figures

Average pain in the previous month (measured on 100 mm visual analogue scale) at baseline, 3-months and 12-months.

Knee-related quality of life (measured by the Knee Injury and Osteoarthritis Outcome Score quality of life [KOOS-QoL] subscale) at baseline, 3-months and 12-months.

Health-related quality of life (measured by European Quality of Life-5 dimensions-5 levels [EQ-5D-5L]) utility score at baseline, 3-months and 12-months.
Similar articles
-
Collins NJ, Smith MD, O'Leary SP, Maclachlan LR, Cottrell MA, Vicenzino B, Vuvan V, Comans T, Kemp JL, Barton CJ, Lee D, McCaskill S, Cush A, Hislop AC, Raymer ME. Collins NJ, et al. Musculoskelet Sci Pract. 2024 Jun;71:102960. doi: 10.1016/j.msksp.2024.102960. Epub 2024 Apr 16. Musculoskelet Sci Pract. 2024. PMID: 38670811
-
Roos EM, Grønne DT, Skou ST, Zywiel MG, McGlasson R, Barton CJ, Kemp JL, Crossley KM, Davis AM. Roos EM, et al. Osteoarthritis Cartilage. 2021 Apr;29(4):502-506. doi: 10.1016/j.joca.2020.12.024. Epub 2021 Feb 6. Osteoarthritis Cartilage. 2021. PMID: 33561542
-
Davis AM, Kennedy D, Wong R, Robarts S, Skou ST, McGlasson R, Li LC, Roos E. Davis AM, et al. Osteoarthritis Cartilage. 2018 Feb;26(2):211-219. doi: 10.1016/j.joca.2017.11.005. Epub 2017 Nov 13. Osteoarthritis Cartilage. 2018. PMID: 29146385
-
Health Quality Ontario. Health Quality Ontario. Ont Health Technol Assess Ser. 2018 Nov 2;18(8):1-110. eCollection 2018. Ont Health Technol Assess Ser. 2018. PMID: 30443280 Free PMC article. Review.
-
Muir D, Orlando C, Newton B. Muir D, et al. Campbell Syst Rev. 2024 Jun 13;20(2):e1406. doi: 10.1002/cl2.1406. eCollection 2024 Jun. Campbell Syst Rev. 2024. PMID: 38873396 Free PMC article. Review.
Cited by
-
Albornoz-Cabello M, Ibáñez-Vera AJ, Barrios-Quinta CJ, Espejo-Antúnez L, Lara-Palomo IC, de Los Ángeles Cardero-Durán M. Albornoz-Cabello M, et al. Biomedicines. 2024 Apr 11;12(4):850. doi: 10.3390/biomedicines12040850. Biomedicines. 2024. PMID: 38672204 Free PMC article.
-
Bhardwaj A, FitzGerald C, Graham M, MacFarlane A, Kennedy N, Toomey CM. Bhardwaj A, et al. Rheumatol Int. 2024 Jun;44(6):1035-1050. doi: 10.1007/s00296-024-05590-9. Epub 2024 Apr 22. Rheumatol Int. 2024. PMID: 38649534 Free PMC article.
-
An anti-inflammatory diet intervention for knee osteoarthritis: a feasibility study.
Cooper I, Brukner P, Devlin BL, Reddy AJ, Fulton M, Kemp JL, Culvenor AG. Cooper I, et al. BMC Musculoskelet Disord. 2022 Jan 13;23(1):47. doi: 10.1186/s12891-022-05003-7. BMC Musculoskelet Disord. 2022. PMID: 35027029 Free PMC article. Clinical Trial.
-
Barton CJ, Pazzinatto MF, Crossley KM, Dundules K, Lannin NA, Francis M, Wallis J, Kemp JL. Barton CJ, et al. Braz J Phys Ther. 2021 Nov-Dec;25(6):854-863. doi: 10.1016/j.bjpt.2021.08.001. Epub 2021 Sep 9. Braz J Phys Ther. 2021. PMID: 34548210 Free PMC article.
-
Docking S, Ademi Z, Barton C, Wallis JA, Harris IA, de Steiger R, Buchbinder R, Brusco N, Young K, Pazzinatto MF, Harries D, Vertullo CJ, Ackerman IN. Docking S, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2436715. doi: 10.1001/jamanetworkopen.2024.36715. JAMA Netw Open. 2024. PMID: 39352701 Free PMC article.
References
-
- Vos T., Lim S.S., Abbafati C., Abbas K.M., Abbasi M., Abbasifard M., et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi: 10.1016/S0140-6736(20)30925-9. - DOI - PMC - PubMed
-
- Nicholls E., Thomas E., van der Windt D.A., Croft P.R., Peat G. Pain trajectory groups in persons with, or at high risk of, knee osteoarthritis: findings from the Knee Clinical Assessment Study and the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2014;22(12):2041–2050. doi: 10.1016/j.joca.2014.09.026. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources